Latest filing published 15 Apr 2026 for Celularity Inc.
Insider track record
Stephen Brigido: trading record in brief
Stephen Brigido (chief executive) discloses dealings in Celularity Inc to SEC (Form 4). In total, 9 filings cover trades dated from 13 April 2022 to 13 April 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 15 April 2026 with an option exercise in Celularity Inc. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen Brigido
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 821 shares0Class A Common StockSEC:0001493152-26-016834:0
- 820 shares0Class A Common StockSEC:0001641172-25-004821:0
- 268 shares@ US$1.642.4% of flowClass A Common StockSEC:0001641172-25-004821:1
- 10,000 shares0Class A Common StockSEC:0001493152-25-007614:0
- 268 shares@ US$4.116.3% of flowClass A Common StockSEC:0001493152-24-014944:0
- 32,720 shares@ US$0.43480.7% of flowClass A Common StockSEC:0001493152-24-007471:0
- 2,683 shares@ US$0.714110.6% of flowClass A Common StockSEC:0000899243-23-011346:0
- 200,000 sharesClass A Common StockSEC:0000899243-23-005917:0
- 32,809 sharesClass A Common StockSEC:0000899243-22-015908:0
9 of 9 declarations
